1 | ONCBPC8A ;HIRMFO/GWB -PCE Study of Cancers of the Urinary Bladder -Print (continued) ;8/15/96
|
---|
2 | ;;2.11;ONCOLOGY;**6,11,16**;Mar 07, 1995
|
---|
3 | IV S TABLE="TABLE IV - FIRST COURSE OF TREATMENT"
|
---|
4 | I IOST'?1"C".E W ! I ($Y'<(LIN-4)) D HDR^ONCBPC8
|
---|
5 | W !?15,TABLE,! D P Q:EX=U
|
---|
6 | S D0=ONCONUM D DFC^ONCOCOM S DOIT=Y
|
---|
7 | W !,"DATE OF INITIAL TREATMENT...........: ",DOIT D P Q:EX=U
|
---|
8 | W !,"PROTOCOL ELIGIBILITY STATUS.........: ",ONC(165.5,IEN,346) D P Q:EX=U
|
---|
9 | W !!,"MANAGING PHYSICIANS:",! D P Q:EX=U
|
---|
10 | W !," PRIMARY PHYSICIAN.................: ",ONC(165.5,IEN,347) D P Q:EX=U
|
---|
11 | W !," SECONDARY PHYSICIAN...............: ",ONC(165.5,IEN,348) D P Q:EX=U
|
---|
12 | W !!,"SURGERY:",! D P Q:EX=U
|
---|
13 | S NCDS=$E(ONC(165.5,IEN,58.1),1,2),NCDSOT=ONC(165.5,IEN,58.1)
|
---|
14 | S CDS=$E(ONC(165.5,IEN,58.2),1,2),CDSOT=ONC(165.5,IEN,58.2)
|
---|
15 | I (CDS="")!(CDS="00") D
|
---|
16 | .S SURG=NCDSOT,SURGDT=ONC(165.5,IEN,58.3)
|
---|
17 | I ((CDS'="")&(CDS'="00"))!(NCDS="") D
|
---|
18 | .S SURG=CDSOT,SURGDT=ONC(165.5,IEN,50)
|
---|
19 | S (SURG1,SURG2)=""
|
---|
20 | S LOS=$L(SURG) I LOS<56 S SURG1=SURG G SURG
|
---|
21 | S NOP=$L($E(SURG,1,42)," ")
|
---|
22 | S SURG1=$P(SURG," ",1,NOP-1),SURG2=$P(SURG," ",NOP,999)
|
---|
23 | SURG I (SURG1="")!($E(SURG1,1,2)="00") S SURGDT="00/00/0000"
|
---|
24 | W !," DATE OF SURGERY...................: ",SURGDT D P Q:EX=U
|
---|
25 | W !," TYPE OF SURGERY...................: ",SURG1 D P Q:EX=U
|
---|
26 | W:SURG2'="" !,?41,SURG2 D P Q:EX=U
|
---|
27 | W !," TUMOR RESECTION DURING TURB.......: ",ONC(165.5,IEN,349) D P Q:EX=U
|
---|
28 | W !," TYPE OF URINARY DIVERSION.........: ",ONC(165.5,IEN,350) ;D P Q:EX=U
|
---|
29 | W !," PELVIC LYMPH NODE DISSECTION......: ",ONC(165.5,IEN,351)
|
---|
30 | I IOST?1"C".E K DIR S DIR(0)="E" D ^DIR Q:'Y D HDR^ONCBPC8 W !?15,TABLE_" (continued)"
|
---|
31 | SC W !!," SURGICAL COMPLICATIONS:",! D P Q:EX=U
|
---|
32 | W !," BLEEDING REQUIRING TRANSFUSION..: ",ONC(165.5,IEN,352) D P Q:EX=U
|
---|
33 | W !," DEEP VENOUS THROMBOSIS..........: ",ONC(165.5,IEN,353) D P Q:EX=U
|
---|
34 | W !," MYOCARDIAL INFARCTION/ARRHYTHMIA: ",ONC(165.5,IEN,354) D P Q:EX=U
|
---|
35 | W !," PELVIC ABSCESS..................: ",ONC(165.5,IEN,355) D P Q:EX=U
|
---|
36 | W !," PNEUMONIA REQUIRING ANTIBIOTICS.: ",ONC(165.5,IEN,356) D P Q:EX=U
|
---|
37 | W !," POST-OPERATIVE DEATH (30 DAYS)..: ",ONC(165.5,IEN,357) D P Q:EX=U
|
---|
38 | W !," PULMONARY EMBOLISM/THROMBOSIS...: ",ONC(165.5,IEN,358) D P Q:EX=U
|
---|
39 | W !," REOPERATION.....................: ",ONC(165.5,IEN,359) D P Q:EX=U
|
---|
40 | W !," OTHER...........................: ",ONC(165.5,IEN,360)
|
---|
41 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y D HDR^ONCBPC8 W !?15,TABLE_" (continued)"
|
---|
42 | RT W !!,"RADIATION THERAPY:",! D P Q:EX=U
|
---|
43 | W !," RADIATION THERAPY.................: ",ONC(165.5,IEN,51.2) D P Q:EX=U
|
---|
44 | W !," DATE RADIATION THERAPY STARTED....: ",ONC(165.5,IEN,51) D P Q:EX=U
|
---|
45 | W !," DATE RADIATION THERAPY ENDED......: ",ONC(165.5,IEN,361) D P Q:EX=U
|
---|
46 | W !," TOTAL RAD (cGy/rad) DOSE..........: ",ONC(165.5,IEN,362) D P Q:EX=U
|
---|
47 | W !," REGIONAL TREATMENT MODALITY.......: ",ONC(165.5,IEN,363) D P Q:EX=U
|
---|
48 | W !!," RADIATION COMPLICATIONS:",! D P Q:EX=U
|
---|
49 | W !," URINARY INCONTINENCE............: ",ONC(165.5,IEN,364) D P Q:EX=U
|
---|
50 | W !," HEMATURIA.......................: ",ONC(165.5,IEN,365) D P Q:EX=U
|
---|
51 | W !," RADIATION BOWEL INJURY..........: ",ONC(165.5,IEN,366) D P Q:EX=U
|
---|
52 | W ! D P Q:EX=U
|
---|
53 | W !,"CHEMOTHERAPY:",! D P Q:EX=U
|
---|
54 | W !," CHEMOTHERAPY......................: ",ONC(165.5,IEN,53.2) D P Q:EX=U
|
---|
55 | W !," DATE CHEMOTHERAPY STARTED.........: ",ONC(165.5,IEN,53) D P Q:EX=U
|
---|
56 | W !," DATE CHEMOTHERAPY ENDED...........: ",ONC(165.5,IEN,367) D P Q:EX=U
|
---|
57 | W !," ROUTE CHEMOTHERAPY ADMINISTERED...: ",ONC(165.5,IEN,368) D P Q:EX=U
|
---|
58 | W !!," TYPES OF AGENTS ADMINISTERED:",! D P Q:EX=U
|
---|
59 | W !," ADRIAMYCIN......: ",ONC(165.5,IEN,369),?33,"IFOSFAMIDE......: ",ONC(165.5,IEN,375) D P Q:EX=U
|
---|
60 | W !," CARBOPLATINUM...: ",ONC(165.5,IEN,370),?33,"METHOTREXATE....: ",ONC(165.5,IEN,376) D P Q:EX=U
|
---|
61 | W !," CISPLATIN.......: ",ONC(165.5,IEN,371),?33,"TAXOL...........: ",ONC(165.5,IEN,377) D P Q:EX=U
|
---|
62 | W !," CYCLOPHOSPHAMIDE: ",ONC(165.5,IEN,372),?33,"THIOTEPA........: ",ONC(165.5,IEN,378) D P Q:EX=U
|
---|
63 | W !," 5-FLUOROURACIL..: ",ONC(165.5,IEN,373),?33,"VINBLASTINE.....: ",ONC(165.5,IEN,379) ;D P Q:EX=U
|
---|
64 | W !," GALLIUM NITRATE.: ",ONC(165.5,IEN,374),?33,"OTHER...........: ",ONC(165.5,IEN,380)
|
---|
65 | I IOST?1"C".E K DIR S DIR(0)="E" D ^DIR Q:'Y D HDR^ONCBPC8 W !?15,TABLE_" (continued)"
|
---|
66 | IFAOA W !!," INDICATION FOR ADMIN OF AGENTS...: ",ONC(165.5,IEN,381) D P Q:EX=U
|
---|
67 | W !," REASON CHEMOTHERAPY STOPPED......: ",ONC(165.5,IEN,382) D P Q:EX=U
|
---|
68 | W !!,"IMMUNOTHERAPY:",! D P Q:EX=U
|
---|
69 | W !," IMMUNOTHERAPY (BRM)...............: ",ONC(165.5,IEN,55.2) D P Q:EX=U
|
---|
70 | W !!," TYPE OF IMMUNOTHERAPY (BRM):",! D P Q:EX=U
|
---|
71 | W !," BCG.............................: ",ONC(165.5,IEN,383) D P Q:EX=U
|
---|
72 | W !," INTERFERON......................: ",ONC(165.5,IEN,384) D P Q:EX=U
|
---|
73 | W !," INTERLEUKIN-II..................: ",ONC(165.5,IEN,385) D P Q:EX=U
|
---|
74 | W !," OTHER...........................: ",ONC(165.5,IEN,386)
|
---|
75 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y D HDR^ONCBPC8 G V
|
---|
76 | D P Q:EX=U
|
---|
77 | V S TABLE="TABLE V - FIRST RECURRENCE"
|
---|
78 | I IOST'?1"C".E W ! I ($Y'<(LIN-4)) D HDR^ONCBPC8
|
---|
79 | W !?15,TABLE,! D P Q:EX=U
|
---|
80 | W !,"TYPE OF FIRST RECURRENCE............: ",ONC(165.5,IEN,387) D P Q:EX=U
|
---|
81 | W !,"DATE OF FIRST RECURRENCE............: ",ONC(165.5,IEN,70) D P Q:EX=U
|
---|
82 | W !,"DISTANT SITE OF FIRST RECURRENCE 1..: ",ONC(165.5,IEN,71.1) D P Q:EX=U
|
---|
83 | W !,"DISTANT SITE OF FIRST RECURRENCE 2..: ",ONC(165.5,IEN,71.2) D P Q:EX=U
|
---|
84 | W !,"DISTANT SITE OF FIRST RECURRENCE 3..: ",ONC(165.5,IEN,71.3) D P Q:EX=U
|
---|
85 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y D HDR^ONCBPC8 G VI
|
---|
86 | D P Q:EX=U
|
---|
87 | VI S TABLE="TABLE VI - STATUS AT LAST CONTACT"
|
---|
88 | I IOST'?1"C".E W ! I ($Y'<(LIN-4)) D HDR^ONCBPC8
|
---|
89 | W !?15,TABLE,! D P Q:EX=U
|
---|
90 | S DLC=""
|
---|
91 | I $D(^ONCO(160,ONCOPA,"F","B")) S DLC=$O(^ONCO(160,ONCOPA,"F","B",""),-1)
|
---|
92 | I DLC'="" S Y=DLC D DATEOT^ONCOPCE S DLC=Y
|
---|
93 | W !,"DATE OF LAST CONTACT OR DEATH......: ",DLC
|
---|
94 | W !,"VITAL STATUS.......................: ",ONC(160,ONCOPA,15) D P Q:EX=U
|
---|
95 | S CS="" I $D(^ONCO(165.5,ONCONUM,"TS","AA")) D
|
---|
96 | .S CSDAT=$O(^ONCO(165.5,ONCONUM,"TS","AA",""))
|
---|
97 | .S CSIEN=$O(^ONCO(165.5,ONCONUM,"TS","AA",CSDAT,""))
|
---|
98 | .S CSPNT=$P(^ONCO(165.5,ONCONUM,"TS",CSIEN,0),U,2)
|
---|
99 | .S CS=$P(^ONCO(164.42,CSPNT,0),U,1)
|
---|
100 | W !,"CANCER STATUS......................: ",CS
|
---|
101 | W !,"COMPLETED BY.......................: ",ONC(165.5,IEN,81) D P Q:EX=U
|
---|
102 | W !,"REVIEWED BY CANCER COMMITTEE.......: ",ONC(165.5,IEN,82)
|
---|
103 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR
|
---|
104 | KILL ;Kill Variables and Exit
|
---|
105 | K %,DIR,DIROUT,DIRUT,DTOUT,DUOUT,LP,FILN,ONCOBL,EX,TXT,X,Y,SCTIEN
|
---|
106 | Q
|
---|
107 | P ;Display Data
|
---|
108 | I ($Y'<(LIN-2)) D Q:EX=U W !?15,TABLE_" (continued)",!
|
---|
109 | .I IOST?1"C".E K DIR S DIR(0)="E" D ^DIR I 'Y S EX=U Q
|
---|
110 | .D HDR^ONCBPC8 Q
|
---|
111 | Q
|
---|